cancer gene therapy (lentiviral vector) (Senti Biosciences)
N/A
Report date: 2025/01/26 19:20:45
Base Information
Drug Namecancer gene therapy (lentiviral vector) (Senti Biosciences)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSenti Biosciences Inc
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksN/A